Minerva Neurosciences Gets FDA Confirmation for NDA for Rolu

By Chris Wack


Minerva Neurosciences said Wednesday that it received confirmation from the Food and Drug Administration that its New Drug Application for roluperidone for the treatment of... | May 10, 2023

Related Keywords

Chris Wack , Minerva Neurosciences , Drug Administration , New Drug Application , Appeal Granted , Prescription Drug User Fee Act , Dow Jones , Nc Stock Exchange , News , Information , Press Release , Y , Chris , Back , Aminerva , Neurosciences , Aid , Wednesday , Hat , It , Eceived , Confirmation , Rom , The , Wood , End , Drug , Administration , Its , Few , Application , Or , Roluperidone , Reatment Nerv Us6033802058 ,